Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
TE

TECH

Market Closed

Bio-Techne Corporation

NASDAQHealthcareBiotechnology
US
3.00K employees
CEO: Kim Kelderman
Founded: 1989
$72.80
+$0.00(+NaN%)
Market Cap
11.44B
Beta
1.27
52W Range
N/A
Dividend Yield
0.44%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Bio-Techne Corporation trades significantly above its intrinsic fair value estimate of $38.73, indicating potential overvaluation with downside risk of nearly 47%. High liquidity and leverage scores contrast with low growth and moderate profitability, suggesting stable but limited expansion prospects. Monte Carlo analysis reveals substantial volatility and consistent downside scenarios below the current price, underscoring elevated investment risk.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore TECH

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

TECH in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →